Main Article Content

Abstract

Antimicrobial resistance (AMR) is the failure of antibiotic to kill bacteria and becomes ineffective in therapeutic purpose. The AMR bacteria is a major health problem worldwide and Indonesia is not exception. AMR is increased by two factors, higher antibiotic use and low compliance in infection control and prevention.  WHO has recommended 7 bacterial indicators as point of view in surveillance, one of these bacteria is Escherichia coli. This study aimed to analyze the correlation between antibiotic use and resistance pattern of gut flora Escherichia coli. The study was conducted at Aisyiyah Hospital, Bojonegoro from June to October 2017. Total 101 patients from internal medicine and surgery department in this hospital were included in this study. Bacterial gut flora were tested against 12 antibiotics by disk diffusion test at the Department of Clinical Microbiology, Universitas Airlangga.. The results showed that the highest quantity of antibiotic use in internal medicine service was cefepime (40,50 DDD) and the highest resistance rate was ciprofloxacin, whereas in the surgical service it was ceftriaxone (132,75 DDD) with the highest E. coli resistance to amoxicillin-clavulanic acid. The antibiotics use has significant correlation against E. coli resistance on cefotaxime (p=0.046), ceftazidime (p=0.046), ceftriaxone (p=0.017), aztreonam (p=0.024), and cefepime (p=0.010).

Keywords

Antimicrobial resistance Escherichia coli antibiotics

Article Details

How to Cite
Hidayah, A. N., Hasmono, D., Thayyib, M., & Kuntaman, K. (2020). The Pattern of Antibiotic Prescription and Antimicrobial Resistance of Gut Flora Escherichia coli at Aisyiyah Hospital, Bojonegoro. Folia Medica Indonesiana, 56(2), 99–107. https://doi.org/10.20473/fmi.v56i2.21227

References

  1. Alekshun MN, Levy SB (2000). Bacterial drug resistance: Response to survival threats, In: Storz, G., Hengge-Aronis R, eds. Bacterial Stress Responses. Washington, ASM Press, p 323-366
  2. Arce JM, Selva M, Perpinan H, Gubernado M, Armero CC, Quilez AL, Gonzales F, Vanachlocha H (2011). Antimicrobial resistance according to age, gender, culture site and patient location in more than 100.000 Escherichia coli. Journal of Antimicrobial Agents Chemotherapy. DOI: 10.1128/AAC.00765-10
  3. Bartoloni A, Benedetti M, Pallecchi L, et al (2006). Evaluation of a rapid screening method for detection of antimicrobial Resistance in the commensal microbiota of the gut. Trans R Soc Trop Med Hyg, 119-125
  4. Barbosa TM, Levy SB (2000). The impact of antibiotics use on resistance development and persistemce. Drug Resist Update 3, 301-311
  5. Carol KC, Butel JS, Morse SA, Mietzner T (2016). Bacteriology in Jawetz, Melnick & Adelberg's medical microbiology. 27th Ed. New York, McGraw Hill Education, p 159-397
  6. Centers for Disease Control and Prevention (2013). Antibiotic resistance threats in the United States. Available at http://www.cdc.gov/drug resistance/threat-report-2013/pdf/ar-threats-2013-508.pdf
  7. Goettsch W, van Pelt W, Nagelkerke N, et al (2000). Increasing resistance to fluoroquinolones in E. coli from urinary tract infection in Netherlands. J. Antimicrob Chemother, 223-228
  8. Kemenkes RI (2015). PMK Nomor 8 Tahun 2015 Tentang Program Pengendalian Resistensi Antimikroba di Rumah Sakit. Jakarta, Kemenkes
  9. Kuntaman K, Lestari E, Severin J, Kershof I, Mertaningsih N, Purwanta M, et al (2005). Fluorokuinolon-resistant Escherichia coli, Indonesia. Emerging Infectious Disease 11, 1363-1369
  10. Lestari ES, Severis JA, Filius PMG, et al (2007). Antimicrobial resisteance among commensal isolates of Escherichia coli and Staphylococcus aureus in the Indonesian population inside and outside hospitals. Eur J Clin Microbiol Infect Di 27, 45-51
  11. Livermore DMR, Hope G, Brick M, Lilie R, Reynolds, BSAC (2008). Working parties on resistance surveillance. Non-susceptibility trends among Pseudomonas aeuginosa and other non-fermentative gram-negative bacteremiaes in UK and Ireland, 2001-06. J. Antimicrob. Chemother 62, ii55-63
  12. Levy SB (2002). Factors impacting on the problem of antibiotic resistance. J. Antimicrob. Chemother 49, 25-30
  13. Li-Yang H, Thean-Yen T, Vincent HT, Andrea K, Dale AF, Tse-Hsien K, The Network for Antimicrobial Surveillance (Singapore) (2010). Surveillance and correlation of antibiotic prescription and resistance of Gram negative bacteria in Singaporean hospital. Antimicrobial Agent and Chemotherapy 54, 1173-1178
  14. Michael CA, Dominey-Howes D, Labbate M (2014). The antimicrobial resistance crisis: Causes, consequences, and management. Infectious Disease 2, 1-8
  15. Pedrera V, Schwarz H, de la Torre MP, Gil-Guillén V, Orozco D, Canelles JM (2004). Analysis of antibiotic use in the community of Valencia (2000-2002). Enferm Infecc Microbiol Clin 22, 385-389
  16. Pottinger P, Reller LB, Ryan KJ (2014). Pathogenic bacteria, in K. J. Ryan, & C. G. Ray, Sherris Medical Microbiology. 6th Ed. New York, McGraw Hill Education, p 253-290
  17. Rice LB (2012). Gastrointestinal bacteria will have its way. The Journal of Infectious Diseases 206, 1334-1335
  18. Rice LB (2016). Mechanism of resistance to antimicrobial agent, in LaPlante, K. L., Cunha, C. B., Morrill, H. J., Rice, L. B, Antimicrobial Stewardship Principle and Practice. 1st Ed.Oxfordshire, CABI, p 39-52
  19. Taur Y, Pamer EG (2013). The intestinal microbiota and susceptibility to infection in immunocompromised patients. Current Opinion in Infectious Diseases 26, 332-337
  20. Todar K (2004). The normal bacterial flora of humans, in Todar’s Online Textbook of Bacteriology. Available at www.textbookofbacteriology.net. Accessed April 6, 2017
  21. WHO (2012). The evolving threat of antimicrobial resistance: Options for Actions. WHO Patient Safety Programme. Geneva, GPS Publishing, p 1-119
  22. WHO (2014). Antimicrobial resistance. Global Report on Surveillance. Geneva, WHO Publishing, p 1-256

Most read articles by the same author(s)

1 2 > >>